Fernando Vieira Pericole

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Fernando Vieira Pericole, Mariana Lazarini, Luciana Bueno de Paiva et al. · Frontiers in Oncology · 2019 · 45 citations · Full text

Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma

Maria Emília Seren Takahashi, Camila Mosci, Edna Marina de Souza et al. · Scientific Reports · 2019 · 43 citations · Full text

Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis

Fernanda Marconi Roversi, Fernando Vieira Pericole, João Agostinho Machado‐Neto et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 33 citations · Full text

Potential Therapeutic Target, Hematological Malignancy, Leukemic Cells +11

Adipose tissue radiodensity: A new prognostic biomarker in people with multiple myeloma

Ademar Dantas da Cunha, Marina Silveira, Maria Emília Seren Takahashi et al. · Nutrition · 2021 · 26 citations

Obesity, Metabolic Syndrome, New Prognostic Biomarker +12

Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression

Simone Cristina Olenscki Gilli, Fernando Vieira Pericole, Bruno Deltreggia Benites et al. · Experimental Hematology · 2016 · 23 citations

Allergy, Disease Mechanism, Medicine +14